SYNCOM FORMULATIONS (INDIA)
|
The Current P/B Ratio of SYNCOM FORMULATIONS (INDIA) is 7.10.
Share Price | ₹21.8 | Dec 12,2024 |
Market Cap | ₹2,045.4 Cr | |
Book Value | ₹288.1 Cr | Mar2024 - Consolidated Results |
Price/Book | 7.10x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of SYNCOM FORMULATIONS (INDIA)
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹2,045.4 Cr] as on Dec 12,2024
(/) Book Value [ ₹288.1 Cr] based on Mar2024 - Consolidated Results
(=) P/B Ratio [ 7.10x ]
Thus, for SYNCOM FORMULATIONS (INDIA) , the investors are currently willing to pay '7.10 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of SYNCOM FORMULATIONS (INDIA) !
The chart below summarizes the trend in P/B Ratio of SYNCOM FORMULATIONS (INDIA) over the last five years.
Historical PB (Price/Book ) ratio chart of SYNCOM FORMULATIONS (INDIA)
PB Ratio Performance Analysis for SYNCOM FORMULATIONS (INDIA)
- SYNCOM FORMULATIONS (INDIA) 's p/b ratio for fiscal years ending Mar2024 to Mar2016 averaged 2.59x.
- SYNCOM FORMULATIONS (INDIA) 's operated at median p/b ratio of 2.17x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SYNCOM FORMULATIONS (INDIA) 's p/b ratio peaked in Mar2022 at 4.22x.
- SYNCOM FORMULATIONS (INDIA) 's p/b ratio hit its five-year low in Mar2017 of 1.31x.
How does SYNCOM FORMULATIONS (INDIA) 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
SYNCOM FORMULATIONS (INDIA) | 288.14 | 7.10 | 2,045.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 63,666.80 | 6.80 | 432,948.0 |
CIPLA LTD | 26,619.90 | 4.39 | 116,809.0 |
DR REDDYS LABORATORIES LTD | 28,123.50 | 3.70 | 103,963.0 |
ZYDUS LIFESCIENCES LTD | 19,829.50 | 4.95 | 98,173.2 |
DIVIS LABORATORIES LTD | 13,571.00 | 11.63 | 157,873.0 |
MANKIND PHARMA LTD | 9,339.84 | 11.37 | 106,198.0 |
TORRENT PHARMACEUTICALS LTD | 6,856.15 | 16.43 | 112,643.0 |
LUPIN LTD | 14,175.80 | 6.81 | 96,581.6 |
AUROBINDO PHARMA LTD | 29,842.80 | 2.36 | 70,576.1 |
ABBOTT INDIA LTD | 3,658.73 | 16.68 | 61,032.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs SYNCOM FORMULATIONS (INDIA) 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.36x |
Max industry PB | 16.68x |
Median industry PB | 6.81x |
Average industry PB | 8.38x |
You may also like the below Video Courses